Valarian Raises $50M to Free Governments From Cloud Grip
London-based Valarian secures a $50 million Series A led by NEA to deploy ACRA, a sovereignty-focused layer that lets...
This guide helps households with multiple incomes implement a zero-based budget, ensuring every dollar is assigned and goals stay aligned.
21,860 articlesLondon-based Valarian secures a $50 million Series A led by NEA to deploy ACRA, a sovereignty-focused layer that lets...
CrowdStrike faced a sharp sell-off for a second consecutive day after a sector-wide reaction to new AI security produ...
Pfizer stock is signaling a shift after years of underperformance. This article breaks down what’s changing, why it m...
With $100, you can start building a resilient energy stock portfolio. This guide breaks down the smartest energy stoc...
Imagine AI agents that remember your preferences across wallets and apps. Walrus Memory makes that possible, letting ...
Small AI plays can jump from obscurity to headlines fast. This guide analyzes the risks and potential rewards, with p...
SpaceX is poised to make a historic move into public markets. This guide breaks down what retail investors should kno...
A dramatic drop from a recent high has investors debating whether Nuscale Power represents a buying opportunity or a ...
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
The idea of an ETF hitting the $1 trillion milestone sounds like fantasy, but it’s worth understanding what it would ...
A new wave of small modular reactors could reshape the US power mix. This article explains why NuScale Power is catch...
KeyBanc boosted its outlook on CrowdStrike, lifting the price target to $700 after signals from the Mythos conference...